Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.

Try Elite for Free

K

KLRS

Kalaris Therapeutics Inc

2.00

Nov 02 • 3:59 PM ET -0.03 (-1.48%)

2.00

Aftermarket • 4:15 PM ET 0.00 (0.00%)

Healthcare Biotechnology USA Nano NASD

Peers: OTLK KOD EYPT OCUL FDMT RGNX REGN IRD OCGN OKYO

| Held by: VTI VXF IWC BUSM DCOR DXUV DFAC

Scroll to Statements

Index	-
Market Cap	43.68M
Enterprise Value	-48.46M
Income	-44.26M
Sales	0.00M
Book/sh	2.42
Cash/sh	4.28
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	20
IPO	Jul 30, 2020

P/E	-
Forward P/E	-
PEG	-
P/S	-
P/B	0.83
P/C	0.47
P/FCF	-
EV/EBITDA	-
EV/Sales	-
Quick Ratio	10.92
Current Ratio	10.92
Debt/Eq	0.02
LT Debt/Eq	0.02
Option/Short	No / Yes

EPS (ttm)	-2.01
EPS next Y	-1.65
EPS next Q	-0.52
EPS this Y	29.78%
EPS next Y	17.43%
EPS next 5Y	5.48%
EPS past 3/5Y	61.69% 45.59%
Sales past 3/5Y	- -
EPS Y/Y TTM	73.44%
Sales Y/Y TTM	-
EPS Q/Q	20.27%
Sales Q/Q	-
Earnings	Aug 11 BMO
EPS/Sales Surpr.	3.03% -

Insider Own	63.69%
Insider Trans	1.79%
Inst Own	25.47%
Inst Trans	-2.35%
ROA	-46.02%
ROE	-79.91%
ROIC	-75.37%
Gross Margin	-
Oper. Margin	-
Profit Margin	-
SMA20	-6.06%
SMA50	-31.14%
SMA200	-62.76%
Trades

Shs Outstand	23.80M
Shs Float	8.64M
Short Float	3.55%
Short Ratio	4.45
Short Interest	0.31M
52W High	11.88 -83.16%
52W Low	1.78 12.36%
Volatility	6.39% 8.42%
ATR (14)	0.17
RSI (14)	35.85
Beta	0.46
Rel Volume	0.86
Avg Volume	68.81K
Volume	59,274

Perf Week	11.11%
Perf Month	-25.93%
Perf Quarter	-53.70%
Perf Half Y	-63.83%
Perf YTD	-76.30%
Perf Year	-60.24%
Perf 3Y	-95.03%
Perf 5Y	-99.62%
Perf 10Y	-
Recom	1.25
Target Price	17.67
Prev Close	2.03
Price	2.00
Change %	-1.48%

Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)